References
- Centers for Disease Control and Prevention. Surveillance report of traumatic brain injury-related emergency department visits, hospitalizations, and deaths—United States. U.S: Department of Health and Human Services; 2014. p. 2019.
- Masel BE, DeWitt DS. Traumatic brain injury: a disease process, not an event. J Neurotrauma. 2010;27(8):1529–40.doi:https://doi.org/10.1089/neu.2010.1358.
- Wang KK, Yang Z, Zhu T, Shi Y, Rubenstein R, Tyndall JA, Manley GT. An update on diagnostic and prognostic biomarkers for traumatic brain injury. Expert Rev Mol Diagn. 2018;18(2):165–80.doi:https://doi.org/10.1080/14737159.2018.1428089.
- Strathmann FG, Schulte S, Goerl K, Petron DJ. Blood-based biomarkers for traumatic brain injury: evaluation of research approaches, available methods and potential utility from the clinician and clinical laboratory perspectives. Clin Biochem. 2014;47(10–11):876–88.doi:https://doi.org/10.1016/j.clinbiochem.2014.01.028.
- Gan ZS, Stein SC, Swanson R, Guan S, Garcia L, Mehta D, Smith DH. Blood biomarkers for traumatic brain injury: A quantitative assessment of diagnostic and prognostic accuracy. Front Neurol. 2019;10:446.
- Meier TB, Nelson LD, Huber DL, Bazarian JJ, Hayes RL, McCrea MA. Prospective assessment of acute blood markers of brain injury in sport-related concussion. J Neurotrauma. 2017;34(22):3134–42.doi:https://doi.org/10.1089/neu.2017.5046.
- Welch RD, Ayaz SI, Lewis LM, Unden J, Chen JY, Mika VH, Saville B, Tyndall JA, Nash M, Buki A, et al. Ability of serum glial fibrillary acidic protein, ubiquitin C-terminal hydrolase-L1, and S100B to differentiate normal and abnormal head computed tomography findings in patients with suspected mild or moderate traumatic brain injury. J Neurotrauma. 2016;33(2):203–14.doi:https://doi.org/10.1089/neu.2015.4149.
- Zetterberg H, Blennow K. Chronic traumatic encephalopathy: fluid biomarkers. Handb Clin Neurol. 2018;158:323–33.
- Rubenstein R, Chang B, Yue JK, Chiu A, Winkler EA, Puccio AM, Diaz-Arrastia R, Yuh EL, Mukherjee P, Valadka AB, et al. Comparing plasma phospho tau, total tau, and phospho tau-total tau ratio as acute and chronic traumatic brain injury biomarkers. JAMA Neurol. 2017;74(9):1063–72.doi:https://doi.org/10.1001/jamaneurol.2017.0655.
- de Guise E, Alturki AY, LeBlanc J, Champoux MC, Couturier C, Lamoureux J, Desjardins M, Marcoux J, Maleki M, Feyz M. The Montreal Cognitive Assessment in persons with traumatic brain injury. Appl Neuropsychol Adult. 2014;21(2):128–35.doi:https://doi.org/10.1080/09084282.2013.778260.
- Delgado C, Araneda A, Behrens MI. Validation of the Spanish-language version of the Montreal Cognitive Assessment test in adults older than 60 years. Neurologia. 2019;34(6):376–85.doi:https://doi.org/10.1016/j.nrl.2017.01.013.
- McKay C, Wertheimer JC, Fichtenberg NL, Casey JE. The repeatable battery for the assessment of neuropsychological status (RBANS): clinical utility in a traumatic brain injury sample. Clin Neuropsychol. 2008;22(2):228–41.doi:https://doi.org/10.1080/13854040701260370.
- Richter P, Werner J, Heerlein A, Kraus A, Sauer H. On the validity of the beck depression inventory. Rev Psychopathol. 1998;31(3):160–68.doi:https://doi.org/10.1159/000066239.
- Bogardus M. Comparison of the center for epidemiology studies depression scale and beck depression inventory for research with Latinas. Issues Ment Health Nurs. 2017;38(2):145–52.doi:https://doi.org/10.1080/01612840.2016.1251513.
- Rappaport M, Hall KM, Hopkins K, Belleza T, Cope DN. Disability rating scale for severe head trauma: coma to community. Arch Phys Med Rehabil. 1982;63(3):118–23.
- Reuter M, Schmansky NJ, Rosas HD, Fischl B. Within-subject template estimation for unbiased longitudinal image analysis. Neuroimage. 2012;61(4):1402–18.doi:https://doi.org/10.1016/j.neuroimage.2012.02.084.
- Desikan RS, Segonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage. 2006;31:968–80.doi:https://doi.org/10.1016/j.neuroimage.2006.01.021.
- Bernal-Rusiel JL, Greve DN, Reuter M, Fischl B, Sabuncu MR, Alzheimer’s disease neuroimaging initiative. Statistical analysis of longitudinal neuroimage data with linear mixed effects models. NeuroImage. 2012;66:249–60.doi:https://doi.org/10.1016/j.neuroimage.2012.10.065.
- Patenaude B, Smith SM, Kennedy DN, Jenkinson MA. Bayesian model of shape and appearance for subcortical brain segmentation. Neuroimage. 2011;56(3):907–22.doi:https://doi.org/10.1016/j.neuroimage.2011.02.046.
- Shi Y, Lai R, Wang DJ, Pelletier D, Mohr D, Sicotte N, Toga AW. Metric optimization for surface analysis in the Laplace-Beltrami embedding space. IEEE Trans Med Imaging. 2014;33(7):1447–63.doi:https://doi.org/10.1109/TMI.2014.2313812.
- Winkler AM, Ridgway GR, Webster MA, Smith SM, Nichols TE. Permutation inference for the general linear model. NeuroImage. 2014;92:381–97.doi:https://doi.org/10.1016/j.neuroimage.2014.01.060.
- Schnakers C, Lutkenhoff ES, Bio BJ, McArthur DL, Vespa PM, Monti MM. Acute EEG spectra characteristics predict thalamic atrophy after severe TBI. J Neurol Neurosurg Psychiatry. 2019;90(5):617–19.doi:https://doi.org/10.1136/jnnp-2017-317829.
- Zhang H. Mixed effects multivariate adaptive splines model for the analysis of longitudinal and growth curve data. Stat Methods Med Res. 2004;13(1):63–82.doi:https://doi.org/10.1191/0962280204sm353ra.
- Mahar I, Alosco ML, McKee AC. Psychiatric phenotypes in chronic traumatic encephalopathy. Neurosci Biobehav Rev. 2017;83:622–30.doi:https://doi.org/10.1016/j.neubiorev.2017.08.023.
- Edwards G 3rd, Moreno-Gonzalez I, Soto C. Amyloid-beta and tau pathology following repetitive mild traumatic brain injury. Biochem Biophys Res Commun. 2017;483(4):1137–42.doi:https://doi.org/10.1016/j.bbrc.2016.07.123.
- Holleran L, Kim JH, Gangolli M, Stein T, Alvarez V, McKee A, Brody DL. Axonal disruption in white matter underlying cortical sulcus tau pathology in chronic traumatic encephalopathy. Acta Neuropathol. 2017;133(3):367–80.doi:https://doi.org/10.1007/s00401-017-1686-x.
- McKee AC, Cairns NJ, Dickson DW, Folkerth RD, Keene CD, Litvan I, Perl DP, Stein TD, Vonsattel JP, Stewart W. The first NINDS/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy. Acta Neuropathol. 2016;131(1):75–86.doi:https://doi.org/10.1007/s00401-015-1515-z.
- DeVos SL, Hyman BT. Tau at the crossroads between neurotoxicity and neuroprotection. Neuron. 2017;94(4):703–04.doi:https://doi.org/10.1016/j.neuron.2017.05.001.
- Ittner A, Chua SW, Bertz J, Volkerling A, van der Hoven J, Gladbach A, Przybyla M, Bi M, van Hummel A, Stevens CH, et al. Site-specific phosphorylation of tau inhibits amyloid-β toxicity in Alzheimer’s mice. Science. 2016;354(6314):904–08.doi:https://doi.org/10.1126/science.aah6205.
- Brion JP, Smith C, Couck AM, Gallo JM, Anderton BH. Developmental changes in tau phosphorylation: fetal tau is transiently phosphorylated in a manner similar to paired helical filament-tau characteristic of Alzheimer’s disease. J Neurochem. 1993;61(6):2071–80.
- Fuster-Matanzo A, de Barreda EG, Dawson HN, Vitek MP, Avila J, Hernández F. Function of tau protein in adult newborn neurons. FEBS Lett. 2009;583(18):3063–68.doi:https://doi.org/10.1016/j.febslet.2009.08.017.
- Hong XP, Peng CX, Wei W, Tian Q, Liu YH, Yao XQ, Zhang Y, Cao FY, Wang Q, Wang JZ. Essential role of tau phosphorylation in adult hippocampal neurogenesis. Hippocampus. 2010;20(12):1339–49.doi:https://doi.org/10.1002/hipo.20712.
- Fuster-Matanzo A, Llorens-Martín M, Jurado-Arjona J, Avila J, Hernández F. Tau protein and adult hippocampal neurogenesis. Front Neurosci. 2012;6:104.doi:https://doi.org/10.3389/fnins.2012.00104.
- Oblinger MM, Das GD. Neurogenesis in the brain stem of the rabbit: an autoradiographic study. J Comp Neurol. 1981;197(1):45–62.doi:https://doi.org/10.1002/cne.901970105.
- Sohur US, Emsley JG, Mitchell BD, Macklis JD. Adult neurogenesis and cellular brain repair with neural progenitors, precursors and stem cells. Philos Trans R Soc Lond B Biol Sci. 2006;361(1473):1477–97.doi:https://doi.org/10.1098/rstb.2006.1887.
- Uematsu M, Nakamura A, Ebashi M, Hirokawa K, Takahashi R, Uchihara T. Brainstem tau pathology in Alzheimer’sdisease is characterized by increase of three repeat tau and independent of amyloid β. Acta Neuropathol Commun. 2018;6(1):1.doi:https://doi.org/10.1186/s40478-017-0501-1.
- Yu CC, Jiang T, Yang AF, Du YJ, Wu M, Kong LH. Epigenetic modulation on tau phosphorylation in Alzheimer’s disease. Neural Plast. 2019;2019:6856327.doi:https://doi.org/10.1155/2019/6856327.
- Olsson B, Lautner R, Andreasson U, Öhrfelt A, Portelius E, Bjerke M, Hölttä M, Rosén C, Olsson C, Strobel G, et al. CSF and blood biomarkers for the diagnosis of Alzheimer’s disease: a systematic review and meta-analysis. Lancet Neurol. 2016;15(7):673–84.doi:https://doi.org/10.1016/S1474-4422(16)00070-3.